MR contrast material for vascular enhancement: Value of superparamagnetic iron oxide

American Journal of Roentgenology

Volumn 166, Issue 1, 1996, Pages 73-77

  Mayo Smith, William W ^a,b   Saini, Sanjay ^a   Slater, Gregory ^a   Kaufman, John A ^a   Sharma, Puneet ^a   Hahn, Peter F ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b RHODE ISLAND HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IRON OXIDE;

ANGIOGRAPHY; ARTICLE; CALCULATION; CONGENITAL BLOOD VESSEL MALFORMATION; CONTRAST ENHANCEMENT; HUMAN; IMAGE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUALITATIVE DIAGNOSIS; QUANTITATIVE DIAGNOSIS; STATISTICAL ANALYSIS; VASCULAR RESISTANCE;

EID: 0030068360     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/ajr.166.1.8571910     Document Type: Article

References (18)

1. Edelman RR. MR angiography: present and future. AJR 1992;161 1-11
2. Runge VM, Kirsch JE, Lee C. Contrast-enhanced MR angiography. J Magn Reson Imaging 1993;3:233-239
3. Prince MR. Gadolinium-enhanced MR aortography. Radiology 1994;191:155-164
4. Yucel EK. MR angiography for evaluation of abdominal aortic aneurysm: has the time come? Radiology 1994;192.321-323
5. Weissleder R. Contrast agents for magnetic resonance angiography. In: Yucel EK, ed. Magnetic resonance angiography, a practical approach. New York: McGraw-Hill, 1994:203-208
6. Weissleder R, Elizondo G, Wittenberg J, Rabito CA, Bersgele HH, Josephson L. Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging. Radiology 1990:175.489-493
7. Pouliquen Î, Perroud H, Calza F Jallet P, Le Jeune JJ. Investigation of the magnetic properties of iron oxide nanoparticles used as contrast agent. Magn Reson Med 1992;24.75-84
8. Chambon C, Clement O, LeBlanche A, Shouman-Claeys E, Frija G. Superparamagnetic iron oxides as positive MR contrast agents: in vitro and in vivo evidence. Magn Reson Imaging 1993;11:509-519
9. Anzai Y, Blackwell KE, Hirschowitz SL, et al. Initial clinical experience with dextran-coated superparamagnetic iron oxides for detection of lymph node metastases in patients with head and neck cancer. Radiology 1994,192:709-715
10. McLachlan SJ, Morris MR, Lucas MA, et al. Phase I clinical evaluation of a new iron oxide MR contrast agent. J Magn Reson Imaging 1994;4:301-307
11. Bengele HH, Palmacci S, Rogers T, et al. Biodistribution of BMS 180549 by different routes of administration. J Magn Reson Imaging 1994;12:433-442
12. Frank H, Weissleder R, Brady TJ. Enhancement of MR angiography with iron oxide: preliminary studies in whole-blood phantom and in animals. AJR 1994;162:209-213
13. Goldberg MA, Yucel EK, Saini S, Hahn PF, Kaufman JA, Cohen MS. MR angiography of the portal and hepatic venous systems: preliminary experience with echoplanar imaging. AJR 1993;160:35-40
14. Nagele T, Klose U, Grodd W, Petersen D, Tintera J. The effects of linearly increasing flip angles on 3D inflow MR angiography. Magn Reson Med 1994;31:561-566
15. Tkach JA, Lin W, Duda JJ, Haacke EM, Masaryk TJ. Optimizing three-dimensional time-of-flight MR angiography with variable repetition time. Radiology 1994;191:805-811
16. Lin W, Tkach JA, Haacke EM, Masaryk TJ. Intracranial MR angiography: application of magnetization transfer contrast and fat saturation to short gradient-echo, velocity-compensated sequences. Radiology 1993;186:7 53-761
17. Parker DL, Blatter DD Multiple thin slab magnetic resonance angiogra-phy. Neurol Imag Clin North Am 1993;2:677-692
18. Stillman AE, Wilke N, Li D, et al. MRA of renal and coronary arteries using an intravascular contrast agent (abstract) Proc Soc Magn Reson 1994,2:944